Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1
Mutations in polymerase ε (POLE) confer favorable prognosis and outcomes in various
cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the …
cancer types, but their role in non-small cell lung cancer (NSCLC) is unknown. Utilizing the …
The evolution of high complexity companion testing for targeted and immuno-oncology
ID Miller - Personalized Medicine, 2016 - Taylor & Francis
Commentary Miller ers simultaneously (eg, EGFR, KRAS, ALK, BRAF), thereby conserving
scarce tissue and potentially speeding time to ultimate actionable result if several tests are …
scarce tissue and potentially speeding time to ultimate actionable result if several tests are …